JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, vol.21, no.1, pp.63-72, 2008 (Journal Indexed in SCI)
Background. Cyclic intravenous pamidronate treatment is widely used for symptomatic therapy of osteogenesis imperfecta (01). However, data after discontinuation are very limited.